Antipsychotic Drugs Market by Therapeutic Class (First Generation, Second Generation, Third Generation), Drug (Aripiprazole, Brexipiprazole, Risperidone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast to 2027
The global antipsychotic drugs market is projected to reach USD ~25 billion by 2027 from USD 14 billion in 2022, at a CAGR of 8% between 2022 and 2027.
To know about the assumptions considered for the study, Request for Free Sample Report
Antipsychotics are prescribed psychiatric medication for treatment of various psychotic symptoms including, delusions, hallucinations, or mania symptoms. Different ways are employed to administer antipsychotic drugs, most common of them is the oral route, in liquid or tablet form. Certain antipsychotic therapeutics are also being prescribed as a depot injection. This route of administration releases medication slowly, slow-acting form and the injection is administered every few weeks. Antipsychotic drugs are prescribed for the regulation of brain circuit functions that control perception, thinking, and mood.
Antipsychotic drugs are categorized into conventional antipsychotics, 2nd-generation antipsychotics (SGAs) and 3rd-generation antipsychotics based on their specific activity and neurotransmitter receptor affinity. SGAs offer certain set of advantages, with respect to efficacy and minimal adverse effects. Recent research studies indicate that new antipsychotic drugs such as muscarinic agonists and trace amines that have novel actions, SGAs comprise majority of the antipsychotics prescribed in the US.
The antipsychotic drugs market is segmented based on disease, therapeutic class, drug, distribution channel, and region. Based on disease, the market is segmented into schizophrenia, bipolar disorder, dementia, unipolar depression, and other diseases. By therapeutic class, the market is segmented into first generation, second generation, and third generation. Based on the drug, the market is segmented into Risperidone, Quetiapine, Aripiprazole, Brexpiprazole, Paliperidone, Palmitate, Olanzapine, and other drugs. The distribution channels analyzed in this market include hospital pharmacies, retail pharmacies/ drug stores, and online pharmacies.
The antipsychotic drugs market includes comprehensive analysis on regions, segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Some of the major players in the global antipsychotic drugs market are Janssen Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., Otsuka Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Allergan, H. Lundbeck A/S, Alkermes Plc, Eli Lilly and Company, Bristol-Myers Squibb Company, and Sumitomo Dainippon Pharma Co. Ltd.
To know about the assumptions considered for the study, download the pdf brochure
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
This report categorizes the antipsychotic drugs market into the following segments
Antipsychotic Drugs Market, By Disease
- Schizophrenia
- Bipolar Disorder
- Dementia
- Unipolar Depression
- Other Diseases
Antipsychotic Drugs Market, By Therapeutic Class
- First Generation
- Second Generation
- Third Generation
Antipsychotic Drugs Market, By Drug
- Risperidone
- Quetiapine
- Aripiprazole
- Brexpiprazole
- Paliperidone
- Palmitate
- Olanzapine
- Other Drugs
Antipsychotic Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies/ Drug Stores
- Online Pharmacies
Antipsychotic Drugs Market, By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest Of Asia Pacific
- Rest Of The World (ROW)
- Latin America
- Middle East And Africa
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 KEY INDUSTRY INSIGHTS
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 PRICING ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PATENT ANALYSIS
5.8 KEY CONFERENCES AND EVENTS IN 2022-2023
5.9 REGULATORY ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 KEY STAKEHOLDER AND BUYING CRITERIA
6 ANTIPSYCHOTIC DRUGS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
6.1 INTRODUCTION
6.2 SCHIZOPHRENIA
6.3 BIPOLAR DISORDER
6.4 DEMENTIA
6.5 UNIPOLAR DEPRESSION
6.6 OTHERS
7 ANTIPSYCHOTIC DRUGS MARKET, BY THERAPEUTIC CLASS, 2020-2027 (USD MILLION)
7.1 INTRODUCTION
7.2 FIRST GENERATION
7.3 SECOND GENERATION
7.4 THIRD GENERATION
8 ANTIPSYCHOTIC DRUGS MARKET, BY DRUG, 2020-2027 (USD MILLION)
8.1 INTRODUCTION
8.2 RISPERIDONE
8.3 QUETIAPINE
8.4 ARIPIPRAZOLE
8.5 BREXPIPRAZOLE
8.6 PALIPERIDONE PALMITATE
8.7 OLANZAPINE
8.8 OTHERS
9 ANTIPSYCHOTIC DRUGS MARKET, BY DISTRIUTION CHANNEL, 2020-2027 (USD MILLION)
9.1 INTRODUCTION
9.2 HOSPITAL PHARMACIES
9.3 RETAIL PHARMACIES/ DRUG STORES
9.4 ONLINE PHARMACIES
10 ANTIPSYCHOTIC DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 ROE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.4 MARKET SHARE ANALYSIS, 2021
11.5 COMPANY EVALUATION QUADRANT
11.6 COMPANY EVALUATION QUADRANT – SME/START-UPS
11.7 COMPANY GEOGRAPHIC FOOTPRINT
11.8 COMPETITIVE SCENARIO
12 COMPANY PROFILES
(The details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view will be provided) *
12.1 JANSSEN PHARMACEUTICALS, INC.
12.2 DR. REDDY’S LABORATORIES LTD.
12.3 OTSUKA PHARMACEUTICAL CO., LTD.
12.4 TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.5 ALLERGAN
12.6 H. LUNDBECK A/S
12.7 ALKERMES PLC
12.8 ELI LILLY AND COMPANY
12.9 BRISTOL-MYERS SQUIBB COMPANY
12.10 SUMITOMO DAINIPPON PHARMA CO. LTD.
12.11 OTHER PLAYERS
* Details on business overview, financial information, products/services portfolio, recent developments, MarketsandMarkets view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
Growth opportunities and latent adjacency in Antipsychotic Drugs Market